pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
131
view
list
cards
Marketed
loxapine
Adasuve (loxapine)
Bipolar Disorder (Manic Depression)
Alexza Pharmaceuticals Inc
Marketed
loxapine succinate
Loxapine Succinate
Schizophrenia
Actavis Elizabeth LLC
Marketed
lubiprostone
Amitiza (lubiprostone)
Opioid-Induced Constipation (OIC)
Mallinckrodt LLC
Phase 3
← prev
page 192 of 231
next →
Pain
89
Neurology
1
lucerastat
lucerastat
Fabry Disease
Idorsia Pharmaceutical Ltd
Phase 2
lucicebtide
lucicebtide
Esophageal Cancer
Sapience Therapeutics Inc
Phase 2
lucinactant
lucinactant
Coronavirus Disease 2019 (COVID-19) Associated Acute Resp…
Lee's Pharmaceutical Holdings Ltd
Phase 2
ludotadipep
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
FutureChem Co Ltd
Phase 2
lufepirsen
Nexagon (lufepirsen [INN])
Persistent Corneal Epithelial Defects
Amber Ophthalmics Inc
Marketed
luliconazole
Luzu (luliconazole)
Tinea Corporis
Bausch Health US LLC
Phase 2
lumacaftor
lumacaftor
Subarachnoid Hemorrhage
Qanatpharma AG
Marketed
lumasiran
Oxlumo (lumasiran)
Primary Hyperoxaluria Type I
$ALNY
ALNYLAM PHARMACEUTICALS, INC.
Phase 2
lunbotinib
lunbotinib [INN]
Non-Small Cell Lung Cancer
Ellipses Pharma Ltd
pre_registration
lunsotogene parvec
lunsotogene parvec
Deafness
$REGN
REGENERON PHARMACEUTICALS, INC.
Marketed
lusutrombopag
Mulpleta (lusutrombopag)
Thrombocytopenia
$SGIOF
SHIONOGI & CO LTD
Phase 3
lutadenovec autogene + sapecmeran autogene
lutadenovec autogene + sapecmeran autogene
Metastatic Colorectal Cancer
Nexoplex Bio LLC
Phase 3
lutetium (177Lu) rosopatamab tetraxetan
lutetium (177Lu) rosopatamab tetraxetan [INN]
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
$TLX
Telix Pharmaceuticals Ltd
Phase 3
lutetium (177Lu) zadavotide guraxetan
lutetium (177Lu) zadavotide guraxetan
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Curium Midco Sarl
Marketed
lutetium Lu 177 dotatate
Lutathera (lutetium Lu 177 dotatate)
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Advanced Accelerator Applications SA
pre_registration
lutetium Lu 177 edotreotide
lutetium Lu 177 edotreotide
Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
ITM Isotope Technologies Munich SE
Phase 2
luvesilocin
luvesilocin [INN]
Post Partum Depression (Maternal Depression / Postnatal D…
Reunion Neuroscience Inc
Phase 2
luvixasertib
luvixasertib [INN]
Human Epidermal Growth Factor Receptor 2 Negative Breast…
Treadwell Therapeutics Inc
Phase 2
luvomeran
luvomeran
Cystic Fibrosis
$VERX
Vertex, Inc.
Phase 2
luvometinib
luvometinib [INN]
Neurofibromatoses Type I (Von Recklinghausen's Disease)
Shanghai Fosun Pharmaceutical (Group) Co Ltd
Preclinical
lysergic acid diethylamide
lysergic acid diethylamide [INN]
Unspecified Psychiatric Disorders
PharmaTher Holdings Ltd
Phase 3
lysergide tartrate
lysergide tartrate
Major Depressive Disorder
$DFTX
Definium Therapeutics, Inc.
Marketed
mNEXSPIKE
mNEXSPIKE
Coronavirus Disease 2019 (COVID-19)
$MRNA
Moderna, Inc.
pre_registration
mRNA-1010
Seasonal Influenza
$MRNA
Moderna, Inc.
Phase 1
mRNA-1215
Nipah Virus (NiV) Infections
$MRNA
Moderna, Inc.
Phase 1
mRNA-1365
Human Metapneumovirus Infections
$MRNA
Moderna, Inc.
Phase 3
mRNA-1403
Norovirus Infections
$MRNA
Moderna, Inc.
